Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
Pharma News, 2025
International Alzheimer
International Alzheimer’s disease prevention trial in at-risk young adults begins
Genentech
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Bain Capital buys Mitsubishi Tanabe Pharma
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
X4 lays
X4 lays off 30% of staff, halts preclinical R&D to focus on Xolremdi rollout
Lipella Pharmaceuticals Granted FDA
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Rani Therapeutics Announces Preclinical
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
FDA grants
FDA grants Orphan Drug Designation to Ariceum cancer therapy
Mozart Therapeutics Presents Compelling
Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn's and Colitis Congress®
Astellas seeks conditional approval for GA treatment in Japan
Astellas seeks conditional approval for GA treatment in Japan
Thermo Fisher
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
IO Biotech Announces Publication
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
FDA Approves Third Biosimilar of Actemra
FDA Approves Third Biosimilar of Actemra
45
46
47
48
49
50
51
52
53
